000728230 000__ 03354cam\a2200421Ii\4500
000728230 001__ 728230
000728230 005__ 20230306141001.0
000728230 006__ m\\\\\o\\d\\\\\\\\
000728230 007__ cr\cn\nnnunnun
000728230 008__ 150720s2015\\\\sz\a\\\\ob\\\\001\0\eng\d
000728230 020__ $$a9783319173627$$qelectronic book
000728230 020__ $$a3319173626$$qelectronic book
000728230 020__ $$z9783319173610
000728230 035__ $$aSP(OCoLC)ocn914165988
000728230 035__ $$aSP(OCoLC)914165988
000728230 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dN$T$$dIDEBK$$dAZU$$dYDXCP$$dSTJ
000728230 049__ $$aISEA
000728230 050_4 $$aRC935.M7
000728230 08204 $$a616.7/48$$223
000728230 24500 $$aMuscular dystrophy$$h[electronic resource] :$$ba concise guide /$$cRaymond A. Huml, editor.
000728230 264_1 $$aCham :$$bSpringer,$$c2015.
000728230 300__ $$a1 online resource (xxiv, 191 pages) :$$bcolor illustrations
000728230 336__ $$atext$$btxt$$2rdacontent
000728230 337__ $$acomputer$$bc$$2rdamedia
000728230 338__ $$aonline resource$$bcr$$2rdacarrier
000728230 504__ $$aIncludes bibliographical references and index.
000728230 5050_ $$aIntroduction to muscular dystrophy / Raymond A. Huml -- Muscular dystrophy : historical background and types / Raymond A. Huml -- FSHD : the most common type of muscular dystrophy?  / Raymond A. Huml and Daniel P. Perez -- Duchenne and Becker muscular dystrophies : underlying genetic and molecular mechanisms / Jean K. Mah -- An overview of the other muscular dystrophies : underlying genetic and molecular mechanisms / Jean K. Mah -- Transition from childhood to adult in patients with muscular dystrophy / Elba Yesi Gerena Maldonado and Kathryn R. Wagner -- Overview of current treatments for muscular dystrophy / Zheng (Jane) Fan -- Physical therapy and orthotic devices / Laura E. Case -- Orthopedic management of the child with muscular dystrophy / Robert K. Lark and Elizabeth W. Hubbard -- Global regulatory landscape / Raymond A. Huml -- Key challenges to the approval of products to treat patients with muscular dystrophy / Raymond A. Huml -- Pharmaceutical products and non-pharmaceutical interventions as potential treatments for patients with muscular dystrophy / Raymond A. Huml -- US patient advocacy groups / Meredith L. Huml -- Global and national patient registries / Raymond A. Huml -- Summary / Raymond A. Huml.
000728230 506__ $$aAccess limited to authorized users.
000728230 520__ $$aThis practical and concise guide offers an overview of muscular dystrophy's (MD) complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long-term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy: A Concise Guide offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.
000728230 588__ $$aOnline resource; title from PDF title page (viewed July 23, 2015)
000728230 650_0 $$aMuscular dystrophy.
000728230 650_0 $$aMuscular dystrophy$$xDiagnosis.
000728230 650_0 $$aMuscular dystrophy$$xTreatment.
000728230 7001_ $$aHuml, Raymond A.,$$eeditor.
000728230 852__ $$bebk
000728230 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-17362-7$$zOnline Access$$91397441.1
000728230 909CO $$ooai:library.usi.edu:728230$$pGLOBAL_SET
000728230 980__ $$aEBOOK
000728230 980__ $$aBIB
000728230 982__ $$aEbook
000728230 983__ $$aOnline
000728230 994__ $$a92$$bISE